| 1 |
19143025 | VIP hypersecretion as primary or secondary syndrome in neuroblastoma: A retrospective study by the Société Française des Cancers de l'Enfant (SFCE). | 2009 May |
1 |
| 2 |
18949372 | Vasoactive intestinal peptide decreases MYCN expression and synergizes with retinoic acid in a human MYCN-amplified neuroblastoma cell line. | 2008 Nov |
2 |
| 3 |
17784840 | Neurospheres derived from human embryoid bodies treated with retinoic Acid show an increase in nestin and ngn2 expression that correlates with the proportion of tyrosine hydroxylase-positive cells. | 2007 Aug |
2 |
| 4 |
12409228 | Suppression of tumorigenicity in neuroblastoma cells by upregulation of human vasoactive intestinal peptide receptor type 1. | 2002 Nov 15 |
1 |
| 5 |
9285932 | Retinoic acid regulation of the VIP and PACAP autocrine ligand and receptor system in human neuroblastoma cell lines. | 1997 |
4 |
| 6 |
7925107 | Characterization of the effects of retinoic acid on vasoactive intestinal polypeptide gene expression in neuroblastoma cells. | 1994 Oct |
3 |
| 7 |
8096334 | VIP potentiates retinoic-acid effect on tissue transglutaminase activity in human neuroblastoma, the SK-N-SH cells. | 1993 Feb |
3 |
| 8 |
8384124 | Interaction of VIP, PACAP and related peptides in normal and leukemic human monocytes and macrophages. | 1993 Mar 15 |
1 |
| 9 |
1319016 | Distinct regulation of vasoactive intestinal peptide (VIP) expression at mRNA and peptide levels in human neuroblastoma cells. | 1992 May 25 |
2 |
| 10 |
1328588 | Autoregulation of neuroblastoma growth by vasoactive intestinal peptide. | 1992 Aug |
2 |
| 11 |
2379178 | In vitro differentiation of human neuroblastoma cells caused by vasoactive intestinal peptide. | 1990 Aug 15 |
3 |
| 12 |
2546814 | Retinoic acid enhances VIP receptor expression and responsiveness in human neuroblastoma cell, SH-SY5Y. | 1989 Jul 3 |
5 |